CLIC4 and ovarian neoplasm: These results suggest that a biomarker panel consisting of CLIC1, CLIC4 and CA125 should outperform individual biomarkers for staining ovarian tumor specimens and could potentially be used in a serum screen assay for all EOC subtypes.